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Abstract
Nucleotide metabolism is a complex pathway regulating crucial cellular processes such as nucleic acid synthesis, DNA 
repair and proliferation. This study shows that impairment of the biosynthesis of one of the building blocks of DNA, dTTP, 
causes a severe, early-onset neurodegenerative disease. Here, we describe two unrelated children with bi-allelic variants in 
DTYMK, encoding dTMPK, which catalyzes the penultimate step in dTTP biosynthesis. The affected children show severe 
microcephaly and growth retardation with minimal neurodevelopment. Brain imaging revealed severe cerebral atrophy and 
disappearance of the basal ganglia. In cells of affected individuals, dTMPK enzyme activity was minimal, along with impaired 
DNA replication. In addition, we generated dtymk mutant zebrafish that replicate this phenotype of microcephaly, neuronal 
cell death and early lethality. An increase of ribonucleotide incorporation in the genome as well as impaired responses to 
DNA damage were observed in dtymk mutant zebrafish, providing novel pathophysiological insights. It is highly remark-
able that this deficiency is viable as an essential component for DNA cannot be generated, since the metabolic pathway for 
dTTP synthesis is completely blocked. In summary, by combining genetic and biochemical approaches in multiple models 
we identified loss-of-function of DTYMK as the cause of a severe postnatal neurodegenerative disease and highlight the 
essential nature of dTTP synthesis in the maintenance of genome stability and neuronal survival.
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Cellular processes such as proliferation and differentiation, 
DNA and RNA synthesis, repair and catabolism require a 
tightly regulated nucleotide metabolism. One of the central 
components here is dTTP (deoxythymidine triphosphate). 
Thymidine nucleotides are biosynthesized by reutilization 
of thymine and thymidine known as the salvage pathway 
(Fig. 1a). Alternatively, dTMP (deoxythymidine monophos-
phate) is formed by the de novo pathway, in which dUMP 
(deoxyuridine monophosphate) is converted to dTMP by 
thymidylate synthase (Fig. 1a). The de novo biosynthetic 
pathway is considered the predominant pathway in actively 
replicating cells, whereas non-cycling cells rely on the sal-
vage metabolism [3].
In this study, we describe a dramatic neurological condi-
tion in two unrelated children (Table 1). Exome analysis 
identified variants in DTYMK (deoxythymidine kinase) that 
segregate with this condition. Functional studies in affected 
fibroblasts and in zebrafish substantiated the evidence of 
a causal relationship. DTYMK encodes dTMPK (deoxy-
thymidine monophosphate kinase), a key enzyme in dTTP 
nucleotide metabolism (Fig. 1a). The thymidine de novo and 
salvage pathways converge at the point of the phosphoryla-
tion of dTMP to dTDP by dTMPK [13]. This makes dTMPK 
the bottleneck for dTTP biosynthesis (Fig. 1a).
This report is the second study showing an association 
between DTYMK and a neurodegenerative condition [17]. 
In the current study, functional evidence and clues towards 
the pathophysiological mechanism are provided for the first 
time. We describe two individuals with pathogenic bi-allelic 
variants in DTYMK and detail the clinical and biochemical 
effects of these deleterious variants in the individuals and 
dtymk-deficient zebrafish.
Materials and methods
Clinical samples, materials and exome sequencing
DNA samples and skin biopsies were obtained from subjects 
in this study following written informed consent in a clinical 
genetic diagnostic setting. DNA was isolated from periph-
eral blood and fibroblasts were grown from skin biopsies. 
Photographs of affected individuals, used in this study were 
obtained after written approval from their legal guardians. 
Dermal fibroblasts were grown from punch skin biopsies in 
Minimal Essential Medium supplemented with l-glutamine, 
antibiotics (Pen-Strep) and 15% fetal bovine serum at 37 °C 
in a humidified atmosphere containing 5%  CO2.
Exomes were captured using the SureSelectXT Human 
All Exon 50 Mb kit (Agilent Technologies) and sequenced 
on an Illumina HiSeq2000 by BGI-Europe (BGI Europe). 
Read mapping was performed using BWA (Burrows-
Wheeler Aligner) and variant calling using GATK (Genome 
Analysis ToolKit).
Brain histology and immunohistochemistry
The brain was fixed in buffered 4% formalin for 3 weeks and 
grossly sectioned. Tissue blocks were embedded in paraf-
fin and cut at 5 µm thickness. Tissue sections were stained 
with Hematoxylin and Eosin (H&E), Klüver-periodic acid 
Schiff (Klüver-PAS) and Nissl according to routine meth-
ods. Immunohistochemistry was carried out as described 
[14] with antibodies against the astrocyte protein glial fibril-
lary acidic protein (GFAP; Millipore, 1:1000), the endothe-
lium marker CD34 (DAKO, 1:200), the microglia marker 
Iba-1 (Wako, 1:10.000), the major mature myelin protein 
proteolipid protein (PLP; Serotec, 1:3000) and the apopto-
sis marker caspase3 (DAKO, 1:500). Positive and negative 
controls by omitting the primary antibody were included in 
each experiment. Briefly, sections were deparaffinized and 
rehydrated. Endogenous peroxidase activity was quenched 
by incubating the slides in 0.3% hydrogen peroxide in meth-
anol. Slides were rinsed with distilled water and transferred 
to citric acid (pH6). Heat-induced antigen retrieval was 
performed using microwave irradiation for 15 min on low 
setting. Tissue sections were then cooled to room tempera-
ture and incubated overnight with primary antibodies. The 
antibody binding was visualized with 3, 3’-diaminobenzi-
dine (DAB) staining. Sections were then counterstained with 
hematoxylin, mounted with polyvinyl alcohol medium with 
Dabco (Sigma) and photographed using a Leica DM6000B 
microscope (Leica Microsystems).
Thymidylate kinase (dTMPK) assay
In vitro dTMPK activity was determined as previously 
described [37]. Briefly, samples were thawed on ice in buffer 
A (320 mM sucrose, 5 mM Tris pH 7.4, 2 mM EGTA (eth-
ylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic 
acid), Triton X-100, 0.05% and protease inhibitors) and 
homogenized. Subsequently, homogenates were centrifuged 
at 16 000×g for 15 min at 4 °C to pellet cellular debris. 
dTMPK activity was measured by incubating the protein 
extracts in a reaction mixture containing 50 mM Tris/HCl, 
pH 7.6, 0.5 mg/ml bovine serum albumin, 5 mM  MgCl2, 
5 mM Dithiothreitol, 5 mM ATP, 30 mM Sodium fluoride 
(NaF), 0.1% Triton X-100 and 25 µM tritium-labeled dTMP 
 ([3H]-dTMP), which was prepared from  [3H]-thymidine 
using thymidine kinase catalyzed reaction. At 0, 10, 20 and 
30 min., 10 µl aliquots were removed and spotted onto Dieth-
ylaminoethyl cellulose (DEAE) filter paper (PerkinElmer) 
and dried. The filter papers were then washed in 50 mM 
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ammonium formate and sorted into scintillation vials. Reac-
tion products were eluted with 0.5 ml of 0.2 M KCl and 
0.1 M HCl, mixed with scintillation fluid and countered in a 
liquid scintillation counter (Tricarb, PerkinElmer).
Zebrafish husbandry and genome editing
Zebrafish (Danio rerio), AB strain, were housed in recircu-
lating systems on a 14/10 day–night regime [18]. All animal 
studies were performed in concordance with the European 
and local guidelines and regulations of Maastricht Univer-
sity on animal experimentation.
Care of animals and animal experiments were conducted 
exclusively by licensed staff.
CrispR/Cas9-mediated genome editing was performed as 
described [10, 33]. A guideRNA (gRNA) targeting exon 4 
(GGG ACT TCC AAA ACC AGA CC) was designed using the 
CHOPCHOP tool [16]. The gRNA was in vitro translated 
using the MEGAShortscript T7-kit (ThermoFisher Scien-
tific). Fertilized oocytes were injected with 100 ng/μl gRNA 
and 200 ng/μl Cas9 mRNA (in vitro transcribed with the 
SP6 mMESSAGE mMACHINE kit (ThermoFisher Scien-
tific) using the pCS2-nCas9n plasmid as a template) [10]. 
Genetically modified founders were identified by genotyp-
ing embryos from outcrosses using HRM (High-Resolution 
Melting curve analysis; see genotyping section) with prim-
ers HRMtmpk_exon4For and HRMtmpk_exon4Rev (Sup-
plementary Table 1, online resource). Modification of the 
locus was confirmed using Sanger sequencing.
Genotyping
Sanger sequencing was performed on lysates of caudal fin 
biopsies of adult zebrafish, embryo lysates or purified DNA 
from human blood or fibroblasts. To this end, target regions 
were amplified by PCR and sequence analysis in both direc-
tions was performed using the ABI Big Dye Terminator 
Cycle Sequencing Ready Reaction kit and the ABI3730 
Genetic Analyzer (Applied Biosystems). The primers used 
to genotype the human samples were: DTYMK_05_F and 
DTYMK_05_R. Genomic modification of the zebrafish 
dtymk locus was confirmed with M13-labeled primers 
zfdtymk_ex4For and zfdtymk_ex4Rev (Supplementary 
Table 1, online resource).
For high-resolution melting curve (HRM) analysis, 
zebrafish embryos were euthanized with a lethal dose of 
MS222 (tricaine). Biopsies from the caudal fin of adult fish 
were taken after anesthesia with MS222. Embryos or fin 
clips were placed individually in lysis buffer, consisting of 
1 M KCl, 1 M  MgCl2, 1 M Tris pH 8.3, Nonidet P40, Tween-
20 and gelatine, supplemented with Proteinase K (100 µg/
ml). Lysis was performed for 1 h at 60 °C, 15 min at 95 °C 
and then held at 4 °C. After adding 80 µl of water, lysates 
were used for PCR. Amplification and HRM analysis were 
performed in the LightCycler ®480 (Roche Applied Sci-
ence), using the HRM Master kit (Roche Applied Science) 
according to the following conditions: 95 °C for 10 min; 45 
cycles of 95 °C for 10 s, 59 °C for 15 s, 72 °C for 15 s; one 
cycle of 95 °C for 60 s, 40 °C for 60 s, and a melting from 
60 °C to 95 °C rising at 0.02 °C per second. All samples 
were run in triplicate. HRM analysis was performed using 
the software LightCycler ® 480 Gene Scanning version 
1.5.1.
Whole‑mount antibody staining and histology
Zebrafish embryos were fixed in 4% paraformaldehyde and 
dehydrated to 100% methanol and stored at − 20 °C until 
further processing. Prior to antibody staining, embryos 
were rehydrated to PBT (PBS + 0.1% Tween) and permea-
bilized using 10 μg/ml proteinase K. After refixation in 4% 
paraformaldehyde, blocking was performed with 10% lamb 
serum, 0.1% Dimethyl sulfoxide (DMSO) for at least 3 h at 
room temperature. Next, the primary antibody was added for 
at least 2 h. After extensive washing, the secondary antibody 
was added for at least 2 h. 3, 3ʹ-diaminobenzidine (DAB)-
staining was performed using the liquid DAB + substrate 
chromogen system (Dako). Stained embryos were visual-
ized and photographed using a stereomicroscope (Leica 
M165 FC). The antibodies used in this study were: anti-
γH2AX (gamma H2A histone family member X) (GeneTex 
GTX127342) and anti-phospho-Histone H3 (Ser10) (pH3) 
(Millipore 06-570).
For histological analysis, embryos were fixed in 4% 
paraformaldehyde and washed in phosphate buffered saline 
(PBS). Next, they were embedded in 2% low-melting point 
agarose to enable correct orientation for sectioning. Agarose 
blocks were trimmed, dehydrated and embedded in paraffin. 
5 μm sections were cut, air dried and stained with eosin/
hematoxylin. Sections were analyzed and photographed on 
a Nikon eclipse e800 microscope.
Apoptotic cells in zebrafish embryos were visualized 
using TUNEL (Terminal deoxynucleotidyl transferase 
dUTP nick end labeling) staining by means of the in Situ 
Cell Death Detection Kit (Roche) according to the manu-
facturers’ instructions.
Head size in larval zebrafish
The size of the head was estimated by measuring the area 
between the eyes of embryos at 2 day post-fertilization (dpf) 
as described in Stankiewics et al. [32]. Briefly, pictures 
of the dorsal view of embryos were taken and the area of 




DNA damage response signalling
To assess the DNA damage response in vivo, zebrafish 
embryos at 24 hpf (hours post-fertilization) were 
UV-irradiated in a UV Stratalinker 1800 (Stratagene) at a 
dose of 12,000 microjoule/cm2. Subsequently, they were left 
to recover for 24 h at 28 °C and processed for antibody stain-




Fibroblasts were labelled with 10 μM EDU (5-ethynyl-2'-de-
oxyuridine) for 30 min, then processed using Click-IT tech-
nology as described by the manufacturer (ThermoFisher Sci-
entific). Subsequently, cells were analyzed in a BD Accuri 
C6 Plus flow cytometer. Profiles were processed using BD 
CSampler software (BD Biosciences).
Alkaline gel electrophoresis
Incorporation of ribonucleotides was investigated using 
alkaline agarose gel electrophoresis as described in Sam-
brook et al. [31]. Genomic DNA was isolated using Qiagen 
Blood and Tissue kit and incubated at 55 °C for 2 h in the 
presence of 300 mM NaOH before electrophoresis on alka-
line agarose gels. DNA was visualized by ethidium bromide 
staining or SYBR Gold staining (Thermo Fisher).
Mitochondrial measurements
Mitochondrial DNA (mtDNA) copy number was measured 
in genomic DNA preparations. mtDNA copy number was 
assessed by comparing expression levels of a mitochondrial 
encoded gene (ND1) versus a nuclear encoded gene (B2M). 
Relative mtDNA copy number was calculated by calculat-
ing ΔCT (= CT nuclear gene, B2M–CT mitochondrial gene, 
ND1) and converting ΔCT to relative expression levels (rela-
tive expression =  2∆CT) as described in Rahn et al. [27].
The integrity of the mitochondrial genome was assessed 
by PCR amplification of the complete mitochondrial genome 
by long-range PCR using Phusion Hot Start polymerase II 
using primers MM_16426_NGS_F and MM16425_NGS_R 
(Supplementary Table 1, online resource), followed by aga-
rose gel electrophoresis.
Complex activity in fibroblasts of individual I and parents 
was analyzed as follows: fibroblasts were cultured and har-
vested for enzyme analysis. Complex activities were deter-
mined as described by Rodenburg and coworkers [29]. This 
assay is a diagnostic assay, performed at the Translational 
Metabolic Laboratory of the Radboud UMC.
Statistical analysis
Statistical evaluation and data presentation were performed 
using GraphPad Prism 8 software. Microsoft Excel was used 
to calculate the exact p values. Statistical significance was 
calculated using the Student’s t test (unpaired, two-sided). 
Differences were considered statistically different when 
p < 0.05. Variance is calculated when comparing different 




The proband was the first child of unrelated Dutch parents 
(Fig. 1b). Family history was uneventful with no prior mis-
carriages. Pregnancy was induced by in vitro fertilization 
because of male subfertility and was complicated by poly-
hydramnios. Third-line ultrasound examinations at 30th and 
36th weeks of gestation, however, showed no explanation 
for the polyhydramnios. No congenital abnormalities were 
observed. Femur length growth was at the 10th centile. The 
fetal brain looked normal and the fetus had a normal fetal 
head circumference, also at the 10th centile (Table 1). There 
was no known teratogenic exposure.
Delivery was uncomplicated at 37 weeks of gestation. 
Birthweight was 2645 g (15th centile Fenton growth chart 
Fig. 1  Description of variants and clinical phenotype. a Overview 
of the dTTP biosynthesis pathway. DTYMK (dTMPK) mediates the 
penultimate step of the generation of dTTP. Both pathways: sal-
vage pathway and de novo pathway converge before the enzymatic 
defect in DTYMK. Abbreviations used: DCK deoxycytidine kinase; 
TK1 thymidine kinase 1; TK2 thymidine kinase 2 (mitochondrial); 
DTYMK deoxythymidine (monophosphate) kinase; DNDPK deoxy-
nucleotide diphosphate kinase; TS thymidylate synthase; RR ribo-
nucleotide reductase; UMPS uridine monophosphate synthetase; 
CAD carbamoyl-phosphate synthase 2, aspartate transcarbamyl-
ase and dihydroorotase; TP thymidine phosphorylase. b Descrip-
tion of two families carrying variants in DTYMK. Both families 
share the variant c.242C>T which is homozygous in individual 
II and indicated in purple. Family I is compound heterozygous and 
contains the additional variant c.382G>A, indicated in red. Brain 
MRI and pictures showing microcephaly in both affected individu-
als. The age of the individuals at which the pictures were taken are 
9  months and 26  months for individual I and individual II, respec-
tively. MRI images of individual I at age 6 months and of individual 
II at 12  months. Both subjects show severe atrophy of the cerebral 
hemispheres and basal ganglia, whereas the thalamus, brain stem 
and cerebellum appear normal. Individual I also shows pronounced 
dilation of the lateral ventricles. c Position of the observed variants 
in the primary protein sequence of dTMPK and relative position of 
known functional domains are shown in the upper panel. The vari-
ants are labelled in purple (p.(Pro81Leu)) and red (p.Asp128Asn). 
Known functional domains of DTYMK are: P-loop motif (indi-
cated in green, residues 13–21), DR(Y/H)-motif (yellow, residues 
96–98), LID domain (blue, residues 135–150) [26]. In the lower 
panel, the position of the variants in the 3D structure (PDB code 
1e2f) are depicted in purple (p.Pro81Leu) and red (p.Asp128Asn). 
d Evolutionary conservation of regions in dTMPK containing the 
described variants. The protein sequences used in the alignment 
are: H.sapiens: ENSP00000304802; S. cerevisiae: YJR057W; D. 
melanogaster: FBpp0303030; D. rerio: ENSDARP00000068373; 
A. carolinensis: ENSACAP00000000660; X. tropicalis: ENSX-





for girls 37 weeks of gestation; 25th centile Perined), occip-
itofrontal circumference (OFC) was 31 cm (2nd centile) and 
height was 44 cm (10th centile); Apgar scores were 9/10 
after 1 and 5 min, respectively. No apparent dysmorphic fea-
tures were observed (Table 1). Because of poor feeding, she 
was readmitted to the hospital on the 3rd day. Nutrition with 
naso-gastric tube was needed and well tolerated. However, 
normal growth was never achieved. The OFC and height pro-
gressively deviated from the normal centiles. She developed 
severe microcephaly with a very puffy appearance (Fig. 1b). 
The girl was hypotonic at birth but developed spasticity with 
opisthotonus within 1 year of age. No neurodevelopmental 
milestones were achieved. No eye contact was ever made. 
She developed recurrent febrile seizures with flat trace EEG 
at 6 months of age which were successfully treated with 
phenobarbital.
Brain MRI at age 3 weeks of life showed slight under-
development of the caudate nucleus and the frontal cortex, 
with severe underdevelopment of the putamen. Brain MRI 
at 6 months of age showed dramatic atrophy of the cerebral 
hemispheres with severe enlargement of the lateral ventricles 
and subarachnoid spaces (Fig. 1b, individual I). At the basal 
ganglia, only the thalamus appeared of normal volume. On 
MRI, the brain stem and cerebellum also appeared normal 
(Fig. 1b, individual I). Microarray showed a normal karyo-
type: 46, XX.
Extensive metabolic investigations were performed 
including urinary organic acids, amino acids, purines & 
pyrimidines, glycosaminoglycans, oligosaccharides, acylg-
lycines, creatine and guanidinoacetate, bile acids and bile 
alcohols. Plasma amino acids, acylcarnitines, very-long 
chain fatty acids, sterols, chitotriosidase, creatine and guan-
idinoacetate, sterols, and plasmalogens were normal. CSF 
amino acids were without abnormalities. At 18 months of 
age she had a respiratory illness. This was complicated by 
cardio-pulmonary arrest, leading to demise.
Post-mortem examination of the internal organs showed 
no abnormalities. Gross neuropathological examination 
showed severe atrophy of the neocortex, cerebral white mat-
ter and basal ganglia, with normal size of brainstem and 
cerebellum (Fig. 2 Overview). Microscopy of the cerebral 
cortical ribbon revealed massive loss of neurons with astro-
gliosis and minimal vascular proliferation (Fig. 2 Histology). 
Whole mounts of the cerebral hemispheres at the level of the 
Table 1  Overview of the most important clinical features of individual I and individual II
Patient I Patient II
Variant, genomic Maternal: Chr2(GRCh37):g.242618013C>T Maternal: Chr2(GRCh37):g.242619732G>A
Paternal: Chr2(GRCh37):g.242619732G>A Paternal: Chr2(GRCh37):g.242619732G>A
Variant, cDNA Maternal: NM_012145.3:c.382G>A NM_012145.3:c.242C>T
Paternal: NM_012145.3:c.242C>T
Variant, protein Maternal: p.Asp128Asn; Paternal: p.Pro81Leu p.Pro81Leu
Origin The Netherlands Egypt
Prenatal findings Polyhydramnios, OFC at 36 weeks 10th centile Slightly smaller head
Microcephaly Yes Yes
Development No developmental progress No developmental progress
Hearing Normal Normal
Vision No tracking of objects, only light/dark No tracking of objects
Sex Female Male
Birth weight, grams / SD 2645 / − 2.3 SD 2250 / − 1.8 SD
Seizures Recurrent febrile seizures myoclonic jerks
Weight, kg / age, months / SD 8,0 / 17 / − 2.6 SD 7.2 / 30 / − 4.0 SD
Height, cm / age, months / SD 58 / 16 / − 6.5 SD 68 / 26 / − 5.4 SD
Head circumference, cm / age, 
months, / SD
34 / 9 / − 7.6 SD 38 / 26 / − 7.4 SD
MRI brain Severe atrophy of cerebral hemispheres and basal 
ganglia
Profound generalized volume loss cerebral cortex
Brain stem and cerebellum appeared normal Cerebellum unaffected
Other findings Puffy body puffy hands and feet, full cheeks
Died at age 18 months Died at age 32 months
Microcytic hypochromic anemia and elevated liver 
enzymes
Micropenis and undescended testis
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Fig. 2  Neuropathology. Over-
view (upper) Panel. Macro-
scopic aspect of the brain of 
individual I. (a, b) Coronal cut 
through the cerebral hemi-
spheres (a, b), cerebellum (a) 
and brainstem (c, pons on the 
left, medulla oblongata on the 
right). Histology (lower) panel. 
Microscopic aspect of the brain 
of individual I. a Whole mounts 
of the cerebral hemispheres 
confirm the massive degree of 
global atrophy (a, haematoxy-
lin and eosin, HE) and show 
paucity of myelin throughout 
the cerebral hemispheres and 
capsules (Kluver-PAS). b–e 
Photomicrographs of the cere-
bral cortex from the frontal lobe 
show loss of neurons, including 
pyramidal cells (b, HE; c, Nissl 
stain for nuclei), astrogliosis (d, 
glial fibrillary acidic protein, 
GFAP) and minimal degree of 
vascular proliferation (e, CD34). 
f, g Photomicrographs of the 
deep white matter adjacent to 
the lateral ventricles show loss 
of oligodendrocytes (f, HE) and 
moderate activation of micro-
glia (IBA-1). h–j The more 
peripheral hemispheric white 
matter shows massive activa-
tion of microglia with ameboid 
morphology (h, IBA-1), lack of 
myelin (i, proteolipid protein 
stain for myelin) and loss of 
oligodendrocytes by apoptosis 
(j, CASP3 stain for apoptotic 
cells). k, l Photomicrographs 
of the basal ganglia (k, HE) 
and thalamus (l, Nissl) show 
loss of neurons and reactive 
gliosis. m, n In the cerebellum, 
microscopic examination shows 
loss of neurons in the granular 
and Purkinje cell layer (m, HE) 
and moderate reaction of the 
Bergmann glia (n, GFAP)
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neostriatum confirm the massive degree of global atrophy 
(Fig. 2a, haematoxylin & eosin, HE) and show paucity of 
myelin throughout the cerebral hemispheres and capsules 
(Fig. 2a, Kluver-PAS). Photomicrographs of the cerebral 
cortex from the frontal lobe show loss of neurons, includ-
ing pyramidal cells (Fig. 2b, HE; c, Nissl stain for nuclei), 
intense anisomorphic astrogliosis (Fig. 2d) and minimal 
degree of vascular proliferation (Fig. 2e). Photomicrographs 
of the deep white matter adjacent to the lateral ventricles 
show loss of oligodendrocytes (Fig. 2f, HE) and moderate 
activation of microglia (Fig. 2g). The more peripheral hemi-
spheric white matter shows massive activation of microglia 
with ameboid morphology (Fig. 2h), lack of myelin (Fig. 2i) 
and loss of oligodendrocytes by apoptosis (Fig. 2j). Photo-
micrographs of the neostriatum (Fig. 2k, HE) and thalamus 
(Fig. 2l, Nissl) show loss of neurons and reactive gliosis. 
In the cerebellum (Fig. 2m, n), microscopic examination 
shows loss of neurons in the granular and Purkinje cell layer 
(Fig. 2m, HE) and moderate reaction of the Bergmann glia 
(Fig. 2n, GFAP).
Individual II
This boy was the second child of healthy consanguineous 
Egyptian parents (first cousins, Fig. 1b). There is a healthy 
older sister. Pregnancy was uneventful, with no known 
teratogenic exposure. At the 32nd week of gestation, the 
prenatal ultrasound showed smaller biparietal diameter for 
gestational age. The individual was born at term by elective 
cesarean. His birth weight was 2250 g (− 1.8 SD) (Table 1). 
His birth height and OFC were not documented but the latter 
was noticed to be small. He stayed in the neonatal intensive 
care unit for 7 days because of neonatal jaundice that was 
treated with phototherapy. The individuals’ parents became 
concerned during the first months of life as he did not offer 
eye contact or track objects. At the age of 7 months, he pre-
sented with fever and repeated vomiting and was admitted 
to the hospital. Severe anemia was detected and treated by 
blood transfusion. The individual underwent multiple analy-
ses of hematological indices and liver enzymes at different 
occasions that always showed microcytic hypochromic ane-
mia and elevated liver enzymes, respectively.
He developed severe myoclonic jerks at 15 months of 
age, which were treated with carbamazepine. The EEG 
demonstrated slow background activity and occasional 
sharp waves. Metabolic work-up including glucose, lactate, 
ammonia, biotinidase, creatine kinase, acylcarnitines, amino 
acids, very long-chain fatty acids and urinary organic acids 
profile were all normal.
At 30 months of age, the boy was referred for genetic 
counseling. On examination, his weight was 7200 g (− 4 
SD), height was 68 cm (− 5.4 SD), and OFC was 38 cm 
(− 7.4 SD) (Table 1). He had fairer hair and skin compared 
to his parents and sister. Bitemporal narrowing, full cheeks, 
puffy hands and feet were noted (Fig. 1b, individual II). Fur-
thermore, he had bilateral undescended testes and micrope-
nis. There was good control of the head and increased tone 
distally in the arms and legs. Tendon reflexes were increased, 
with bilateral clonus and positive Babiniski signs. He made 
almost no developmental progress: he did not roll over, sit, 
vocalize, or smile. Ophthalmologic examination and hearing 
test were normal. Serum electrolytes, urea, creatine, albumin 
level and 17-hydroxyprogesterone were all normal. Chromo-
some analysis showed a normal 46, XY karyotype. Brain 
MRI and CT at age 2 years showed profound generalized 
cerebral atrophy with widening of the subarachnoid spaces 
(Fig. 1b, individual II). The basal nuclei were small, but 
visible, while the thalamus appeared to have a normal size. 
Also, the brain stem and cerebellum were spared (Fig. 1b, 
individual II). At the age of 32 months, the boy developed a 
pneumonia followed by coma and death.
At birth, no apparent dysmorphic features were observed 
in both children. In the months following birth, the fol-
lowing phenotypic features became apparent in both indi-
viduals: growth retardation, puffy body, seizures, failure to 
reach developmental milestones, microcephaly and severe, 
progressive atrophy of the cerebral hemispheres and basal 
ganglia (Table 1). Pathology in individual I confirms mas-
sive neuronal dropout, only sparing the dentate nucleus and 
brain stem.
2. Description of variants in DTYMK
Exome sequencing identif ied compound het-
erozygous variants in DTYMK (Deoxy Thymidylate 
Kinase) in family I: Chr2(GRCh37):g242619732G>A; 
NM_012145.3 :c .242C>T;  p .Pro81Leu  (pa te r-
n a l )  a n d  C h r 2 ( G RC h 3 7 ) : g 2 4 2 6 1 8 0 1 3 C > T; 
NM_012145.3:c.382G>A; p.Asp128Asn (maternal) 
(Fig. 1b; Table 1). In the second case (individual II), one of 
the abovementioned variants, Chr2(GRCh37):g242619732
G>A;NM_012145.3:c.242C>T; p.Pro81Leu was observed 
in a homozygous state. (Fig. 1b; Table 1).
Variant c242C>T, p.(Pro81Leu) is a missense substitu-
tion of a highly conserved nucleotide (phyloP: 5.29 [− 14.1; 
6.4]) leading to a change in a moderately conserved amino 
acid (considering 13 species) (Fig. 1d). Predictions of the 
amino acid change, p.(Pro81Leu), varied from tolerated 
(SIFT, score: 0.19, median: 2.82) to “possibly damaging” 
(PolyPhen2 score 0.885) to disease causing (MutationTaster, 
p value: 1). This variant is unknown to ESP and ExAC. In 
dbSNP, it is known as rs1267106442 and is found once in 
gnomAD with a MAF of 0.0000319, but only in a heterozy-




The second variant, c.382G>A, p.(Asp128Asn) is also a 
missense substitution involving a highly conserved nucleo-
tide (phyloP: 5.61 [− 14.1; 6.4]), giving rise to a change in 
a highly conserved amino acid, up to Saccharomyces cerevi-
siae (considering 13 species) (Fig. 1c, d). SIFT-prediction 
was tolerated (score: 0.09, median: 2.82), whereas Mutation-
Taster and Polyphen-2 predicted this variant to be disease-
causing (p value: 1) and probably damaging (score 1.00), 
respectively (Supplementary Fig. 2a, online resource). This 
variant is known to bSNP as rs373875797 (MAF/MinorAl-
leleCount: T = 0.000/0) and to ESP as ESP6500SIV2. This 
variant has been reported twice in the ExAC database (MAF: 
0.00001649), but never in a homozygous state. This variant 
is known to gnomAD and appears 4 times with a MAF of 
0.00001591, but only in a heterozygous state (accessed on 
04/05/2021). Both variants are not located in a known func-
tional domain of the protein (Fig. 1c).
3. Zebrafish dtymk knockout model
To study the relationship between neurodegeneration and 
dTMPK deficiency, we generated a dtymk knockout model 
in zebrafish (Fig. 3). Sequencing of homozygous mutant 
embryos revealed a 5-bp deletion in exon 4 (Fig. 3a). This 
modification leads to a premature stop codon, 19 amino 
acids downstream of the deletion, whereas the wildtype pro-
tein contains another 85 amino acids. The first 127 amino 
acids (60%) of the tmpk protein upstream remain unaltered 
(Fig. 3a).
At 5 dpf, all homozygous dtymk mutant embryos show 
small eyes, pericardial edema and edema around the intes-
tine, while 2/3 of the mutant embryos also had exten-
sive edema of the brain (Fig. 3b; Supplementary Fig. 2b, 
online resource). The fraction of affected embryos was 
consistent with the expected fraction from a heterozygous 
incross (25%), and confirmed by genotyping (Supplemen-
tary Fig. 2b, online resource). From 3dpf onwards, dtymk 
mutant embryos can be morphologically distinguished from 
their siblings as the eyes are markedly smaller and pericar-
diac edema is prominent. Remarkably, mutant embryos at 
3dpf show twitching movements, reminiscent of epilep-
tic seizures although other causes (eg. motor neuron dys-
function) cannot be excluded. From 4dpf onwards, mutant 
embryos develop prominent edema of the brain and around 
the intestine. At 5dpf, more than 40% of mutant embryos 
have died. Since affected individuals show microcephaly, 
the head size of mutant and sibling embryos was quanti-
fied at 2dpf (Fig. 3d). A timepoint early in development was 
chosen to avoid brain edema interfering with the assess-
ment of head size. Head size was found to be significantly 
(p = 1.52 ×  10–13) smaller when compared to sibling embryos 
of the same batch (Fig. 3d). The length of sibling vs. mutant 
embryos was not different (Supplementary Fig. 1c), ruling 
out developmental delay as the cause of microcephaly in 
dtymk mutant zebrafish.
Histology of 3- and 5-day-old embryos provided a more 
detailed insight into the phenotype (Fig. 3c). In the brain, 
empty spaces, indicative of neurodegeneration are appar-
ent in the mutant embryos (Fig. 3c, blue star). In addition, 
cartilage structures of the lower jaw (Meckels’ cartilage) 
are absent in the mutant larvae (Fig. 3c blue arrows). Severe 
underdevelopment of the eyes is prominent: the eyes of 
mutant embryos are smaller, have an irregular shape and 
only show the retinal pigmented epithelium (RPE) and pho-
toreceptor layer (PRL), whereas the other 4 layers are absent 
(Supplementary Fig. 2d, online resource).
TUNEL staining at 2dpf revealed higher amounts of 
apoptotic cells in dtymk mutant zebrafish. We quantified the 
number of TUNEL-positive cells in the forebrain of dtymk 
mutant zebrafish and found that dtymk mutant embryos 
have significantly more apoptotic cells in the forebrain 
when compared to wildtype (p = 6.45 ×  10–6) or heterozy-
gous (p = 7.54 ×  10–6) siblings (Fig. 4e, f).
These results, together with the observation of extensive 
postnatal cerebral atrophy in both individuals and the pres-
ence of apoptotic oligodendrocytes in the brain of individual 
I (Fig. 2j) demonstrate that neuronal cell death is a hall-
mark of the disease phenotype as it is prominent in both 
the affected individual as the zebrafish model as a result of 
dtymk deficiency.
4. DTYMK alleles in affected individuals and zebrafish are 
loss-of-function
The functional effect of the variants, observed in the 
individuals and the deletion in the zebrafish model were 
assessed at the biochemical level using an in vitro dTMPK 
assay [37]. To this end, dTMPK activity was measured in 
cultured fibroblasts of family I (Fig. 4a). In fibroblasts of 
the parents, dTMPK activity was readily detectable. In the 
mother, an activity of 43.65 pmol/min/mg protein was meas-
ured, whereas the cells of the father showed lower activity: 
31.08 pmol/min/mg protein. dTMPK activity of the indi-
vidual was hardly detectable: 0.62 pmol/min/mg protein. 
dTMPK enzyme activity of the individual is significantly 
lower than those of the parents (mother vs. individual I 
p = 1.46 ×  10–6; father vs. individual p = 5.77 ×  10–6).
In the zebrafish model, pools of 35–50 larvae of 5dpf 
were phenotyped and processed for dTMPK enzyme activity 
measurements (Fig. 4b). The sibling embryos had a dtmpk 
activity of 38.55 pmol/min/mg protein, which is compara-
ble to the activity measured in the fibroblasts of the par-
ents. Dtymk mutant embryos on the other hand had barely 
detectable activity: 1.80 pmol/min/mg protein. Unrelated 
wildtype larvae of the same age showed a dtmpk activity 
of 41.43 pmol/min/mg protein. Dtmpk activity of mutant 
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larvae is significantly lower than those of sibling larvae 
(p = 0.0028) or wildtype larvae (p = 0.0001) (Fig. 4b).
Similar results from fibroblasts of an affected individual 
and knockout zebrafish confirm that the tested alleles in 
fibroblast and zebrafish represent loss-of-function alleles, 
giving rise to a non-functional dTMPK enzyme, shown by 
the very low dTMPK activity in both models.
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5. DTYMK disease alleles cause impaired DNA replication, 
elevated ribonucleotide incorporation and altered DNA 
damage signaling
Since the effect of the variants in DTYMK completely 
blocks the known biosynthesis pathway of dTTP, we 
evaluated processes that require significant amounts of 
nucleotides including DNA replication and aspects of 
DNA repair. To assess DNA replication, we performed 
pulse-EdU staining of fibroblasts from individual I and 
the parents to quantify the number of cells in S-phase of 
the cell cycle (Fig. 4c). Flow cytometry analysis of EdU-
labeled fibroblasts showed that in the parents of family I, 
the number of S-phase cells is 23.65% and 16.03% in the 
mother and father, respectively. In contrast, the fraction 
of S-phase cells in individual I fibroblasts was only 2.8%. 
This is significantly lower than the amounts in the fibro-
blasts of the mother (p = 0.0180) and father (p = 0.0249) 
(Fig.  4c). These results show that DNA replication is 
impaired in fibroblasts of affected individuals.
As the principal phenotype in the individuals is neuro-
logical, we next assessed cell proliferation in the brain of 
dtymk mutant zebrafish larvae at 2dpf using phospho-Ser10 
Histone H3 (pH3) staining. Histone H3 is phosphorylated 
at Ser10 by cyclin dependent kinase 1 in late G2 phase and 
mitosis and is a frequently used marker for cell proliferation. 
The number of proliferating cells in the forebrain of dtymk 
mutant and sibling embryos at 2dpf was evaluated (Fig. 4d). 
Quantification was limited to the forebrain as this is the 
homologous structure to the human cerebral cortex, which 
is most affected in the affected individual. As the larvae are 
morphologically undistinguishable at 2dpf, the number of 
proliferating cells in the forebrain of individual embryos 
was counted and embryos were subsequently genotyped. 
We found the number of pH3-positive cells in the forebrain 
of dtymk mutant embryos to be significantly lower than the 
number of proliferating cells in wildtype (p = 0.0008) and 
heterozygous (p = 0.0004) dtymk embryos (Fig. 4d). When 
comparing the sibling embryos, there is no difference in the 
number of proliferating cells in wildtype versus heterozy-
gous dtymk embryos. In summary, we find severe defects in 
DNA replication in individual I-derived fibroblasts and in 
proliferation in the brain of dtymk mutant zebrafish.
As the biosynthesis of one of the nucleotides for DNA 
synthesis and repair is impaired, one could expect nucleotide 
pool imbalance in mutant fibroblasts and zebrafish. One of 
the most common consequences of nucleotide imbalance 
is the incorporation of ribonucleotides into genomic DNA 
[36]. Ribonucleotides differ from deoxyribonucleotides by 
the presence of a single reactive hydroxyl group at the 2’ 
position of the ribose sugar, making RNA more susceptible 
to spontaneous hydrolysis [20]. The presence of ribonucleo-
tides in genomic DNA is not favorable as they can impair 
DNA replication and render DNA more sensitive to strand 
breakage, leading to genome instability. We evaluated the 
presence of ribonucleotides in the genomic DNA by alka-
line hydrolysis and subsequent alkaline gel electrophore-
sis (Fig. 5a, b). These experiments show that the genomic 
DNA isolated from dtymk –/– embryos migrates at a lower 
position and is more fragmented, indicated by a broader 
smear, in an alkaline agarose gel (Fig. 5a). This indicates a 
marked increased sensitivity of the genomic DNA of dtymk 
–/– embryos to alkaline hydrolysis reflective of elevated 
incorporation of ribonucleotides. When compared to the 
DNA from cells from Rnaseh2 –/– mice, a mutant strain 
known to incorporate high amounts of ribonucleotides in the 
genome [6, 28], the genomic DNA of dtymk –/– zebrafish 
shows a similar degree of fragility resulting in a broad smear 
of lower molecular weight and lower intensity (Supplemen-
tary Fig. 3c, online resource).
Virtually all DNA repair pathways involve some degree 
of repair-associated DNA synthesis. The effects of DTYMK 
deficiency on the process of DNA damage signaling was 
evaluated in vivo. Embryos were UV-irradiated at 24hpf. 
DNA breakage was visualized by γH2AX staining. The 
embryos were allowed to recover for 24 h and the number of 
γH2AX-positive cells, visible as small black dots throughout 
the embryo, in dtymk mutant fish was evaluated (Fig. 5c, d). 
From a batch of embryos from a heterozygous incross, two 
distinct populations can be discriminated: one group with 
high amounts of strongly stained γH2AX cells and another 
group with no to very low levels of γH2AX-positive cells. 
The fraction of embryos from a dtymk heterozygous incross 
with high amounts of γH2AX-positive cells was about 25%. 
Genotyping confirmed that these were the dtymk homozy-
gous mutant fraction. This analysis shows elevated levels of 
γH2AX persisting in the dtymk mutant embryos 24 h post 
UV-irradiation compared to the wild-type (sib) counterparts. 
This abnormally elevated DNA damage response signaling 
Fig. 3  dtymk knockout zebrafish. a Genomic location of the gRNA 
sequence used to generate the knockout line of dtymk, indicated 
in yellow. The mutant line, Δex4 contains a 5-bp deletion in exon 
4 resulting in a truncated protein. b Phenotype of dtymk knockout 
(dtymk –/–) embryos at 5dpf and their siblings (sib). The homozy-
gous mutant embryos (dtymk –/–) show small, irregular eyes and 
edema around the brain, heart and intestine. The scale bar represents 
200 μm. c Hematoxylin/eosin staining of transversal sections through 
the head of sibling and dtymk mutant embryos at 3dpf and 5dpf at 
the level, where the optic nerve exits the eye. Images show prominent 
degeneration of brain tissue (blue star) and structural abnormalities 
of the eyes and jaw cartilage structures (blue arrow) in the mutant 
embryos (dtymk –/–) which is absent in the sibling (sib) embryos. The 
scale bar represents 100 μm. d Quantification of head size in dtymk 
–/– and sibling (sib) embryos at 2dpf. Average head size of 19–24 
embryos at 2dpf showing significant microcephaly in mutant vs. sib-
ling embryos (***, p = 1.52 ×  10–13). Error bars show the standard 




is consistent with elevated levels of unrepaired DNA breaks 
in the dtymk mutants under these conditions (Fig. 5c, d).
In a recent study, DTYMK was suggested to cause mito-
chondrial DNA (mtDNA) depletion [29]. Therefore, we 
studied the mitochondrial genome and function in cultured 
fibroblasts of individual I (Fig. 6) and the parents of indi-
vidual I. For additional reference, we included 5 fibroblast 
samples of healthy controls. The mtDNA copy number 
in fibroblasts of individual I was found to be lower than 
that of the parents but this was not statistically different. 
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Moreover, mtDNA copy number in fibroblasts of the par-
ents of individual I is higher than in control fibroblasts 
(Fig. 6a) and the mtDNA copy number of individual I is 
in the same range as the control cells.
Deficiencies in the replication machinery of the mtDNA 
can also result in deletions in the mtDNA. Therefore, we 
studied the integrity of the mitochondrial genome by means 
of long-range PCR, amplifying the complete mitochondrial 
genome (Fig. 6b). The mitochondrial genome amplified from 
individual I and its parents migrate at the expected length 
of 16,5 kilobases and show no indications of mtDNA dele-
tions. We conclude that the mtDNA copy number and integ-
rity are not compromised by DTYMK deficiency. Finally, 
mitochondrial function was assessed. We evaluated enzyme 
activity of respiratory complexes I–V using a spectropho-
tometric assay as used in mitochondrial disease diagnostics 
(Fig. 6c). individual I shows no significant alterations in the 
enzyme activities of complexes I–V, indicating that mito-
chondrial respiratory function in individual I is comparable 
to that of the parents. In conclusion, we find no significant 
indications of mitochondrial dysfunction in fibroblasts of 
individual I.
Discussion
We report loss-of-function of DTYMK as the genetic cause 
of a novel, severe neurodegenerative disease in two unrelated 
individuals with a dramatic neurodevelopmental decline. 
Brain pathology confirmed massive neuronal dropout in 
virtually the entire brain, sparing the brain stem. This strik-
ing neurodegenerative phenotype is also observed in dtymk 
mutant zebrafish which exhibit microcephaly, brain edema 
and neuronal apoptosis (Fig. 3). These results, as well as the 
cerebral atrophy that only sets in postnatally and the pres-
ence of apoptotic cells in the brain of individual I (Fig. 2j) 
implicate neuronal apoptosis as one of the hallmarks of this 
disease.
This report is the second study describing DTYMK vari-
ants in the context of human disease. Lam et al. recently 
reported two brothers with microcephaly, hypotonia and 
severe intellectual disability showing compound heterozy-
gous variants in DTYMK [17]. They predicted mitochondrial 
depletion in one of the affected individuals, but functional 
data to support a mitochondrial defect was not provided 
[17]. In the current study, we present DTYMK variants in 
two unrelated families and provide biochemical data from 
fibroblasts of affected individuals and an additional animal 
model. Furthermore, we demonstrate important aspects of 
the pathogenic mechanism. Although the clinical phenotype 
of our individuals highly resembles that described previ-
ously, we could not document mtDNA depletion. (Fig. 6a). 
We acknowledge that measurement of mtDNA copy num-
ber in fibroblasts (or peripheral blood) is not representative 
for the copy number in affected tissues, as compensatory 
mechanisms can mask mtDNA depletion [9, 30]. For diag-
nostic purposes, mtDNA copy number can only be reli-
ably assessed in a muscle biopsy of affected individuals. 
Unfortunately, we do not have access to muscle tissue of 
the described individuals. Still, additional functional studies 
failed to demonstrate mitochondrial dysfunction. Mitochon-
drial parameters, mtDNA integrity and respiratory chain 
activity, were all within the normal range in individual I. 
Also, all biochemical indicators for mitochondrial dysfunc-
tion from our individuals that were measured in serum and 
Fig. 4  dTMPK activity and replication defects in fibroblasts and 
zebrafish. a dTMPK activity measured in fibroblasts of family I. In 
both parents, activity was readily detected and was lower in the fibro-
blasts of the father. dTMPK activity was hardly detectable in indi-
vidual I (n = 6). Mother vs. individual I (***, p = 1.46 ×  10–6, unequal 
variance). Father vs. individual I (***, p = 5.77 ×  10–6, unequal vari-
ance). b dtmpk activity in lysates of zebrafish at 5dpf. Lysates were 
prepared from pools of 35–50 embryos of indicated genotypes. 
n = 2–3 and measurements were performed 2 times. dtmpk activity 
was negligible in mutant embryos and robustly detected in both sib-
ling embryos as embryos of the same age from an unrelated wildtype 
strain (AB). Wt vs. mut: **, p = 0.0001); Sib vs. mut: *, p = 0.0028. 
c EdU incorporation in the fibroblasts of family I. Representative 
flow cytometry profiles are shown from fibroblasts of the individual 
and the parents. The red boxes denote the EdU positive (S-phase) 
cell populations. Quantification of the percentage of EdU-positive 
(S-phase) cells shows that the fibroblasts of individual I have signifi-
cantly fewer proliferating cells when compared to the fibroblasts of 
the mother (*, p = 0.0180, unequal variance) and father (*, p = 0.0249, 
unequal variance). Indicated values are average % of EdU-positive 
cells ± SEM, n = 4). d Whole-mount pH3-immunostaining show-
ing proliferating cells in wildtype (dtymk + / +), heterozygous 
(dtymk+/−) and dtymk-knockout (dtymk –/–) embryos at 2dpf. Rep-
resentative images of side-view of an embryo with many proliferating 
cells (black dots, right image) and an embryo with less proliferating 
cells (left image). The red, dotted rectangle represents the area that 
was analyzed for the quantification of the number of proliferating 
cells in the forebrain. The scale bar represents 200  μm. Quantifica-
tion of the number of pH3-positive cells in the brain indicates that 
the mutant embryos have significantly less pH3-positive cells in the 
brain when compared to wildtype (**, p = 0.0008) and heterozygous 
(**, p = 0.0004) embryos, n = 9–24 embryos per group, two biologi-
cal replicates. Indicated values are average ± SEM. e Whole-mount 
TUNEL staining showing apoptotic cells in sibling (sib: dtymk+/+or 
dtymk+/−) and dtymk-knockout (dtymk –/–) embryos at 2dpf. Rep-
resentative frontal images of an embryo with many apoptotic cells 
(black dots, left image, dtymk –/–) and an embryo with less apoptotic 
cells (right image, sib). The white, dashed area represents the fore-
brain, the area that was analyzed for the quantification of the num-
ber of apoptotic cells in the forebrain. Embryos were genotyped after 
staining and imaging. The scale bar represents 200  μm. f Quantifi-
cation of the number of apoptotic cells in the forebrain in wildtype, 
heterozygous and dtymk-knockout embryos at 2dpf. The mutant 
embryos have significantly more (***, p < 0.0001) apoptotic cells in 
the forebrain when compared to wildtype (***, p = 6.45 ×  10–6, equal 
variance) and heterozygous (***, p = 7.54 ×  10–6, unequal variance) 
embryos, n = 23–46 embryos per group, two biological replicates. 




urine were normal: lactate and alanine levels were normal 
and no generalized hyper aminoaciduria was observed.
Several other disease-causing genetic defects in human 
dTTP metabolism are known. Thymidine phosphorylase 
(TP) deficiency causes MNGIE, Mitochondrial Neuro Gas-
tro-Intestinal Encephalomyopathy [24]. TP catalyses the 
cleavage of thymidine into ribose-1-phosphate and thymine 
(Fig. 1c). When accumulation of dTTP occurs, dNTP pool 
imbalance is promoted, leading to mtDNA depletion [12]. 
Inactivating variants in RRM2B, encoding part of Ribonu-
cleotide Reductase (RR) causes a severe mtDNA deple-
tion syndrome that is fatal in the neonatal period [4]. RR 
catalyses the reduction of ribonucleoside diphosphates to 
deoxyribonucleoside diphosphates in the de novo biosyn-
thetic pathways of all four canonical dNTP. Another human 
neurodegenerative disease, linked to dTTP metabolism and 
caused by pathogenic variants in CAD (Fig. 1a) is develop-
mental and epileptic encephalopathy 50 (DEE50) [15, 22]. 
This is an autosomal recessive, progressive neurodegenera-
tive neurometabolic disorder characterized by delayed psy-
chomotor development, early onset seizures, severe develop-
mental regression, and normocytic anemia. Onset is within 
the first months or years of life [15, 22]. Lastly, DTYMK 
deficiency resembles Aicardi–Goutières syndrome (AGS), 
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both at the clinical as at the pathophysiological level. AGS 
is characterized by progressive microcephaly, psychomotor 
retardation and often death in early childhood [8]. White 
matter destruction and brain atrophy are shared phenotypic 
features of AGS and DTYMK deficiency. Clinical differ-
ences are that in AGS, intracranial calcification and systemic 
features (thrombocytopenia, hepatosplenomegaly and cer-
ebrospinal fluid lymphocytosis) are present [2]. Importantly, 
at the mechanistic level, AGS and DTYMK deficiency are 
similar as both are characterized by elevated ribonucleotide 
incorporation in the genome. In AGS, this is explained by 
pathogenic variants in the genes encoding ribonuclease H2 
subunits [8]. Ribonuclease H2 is the key enzyme, involved 
in ribonucleotide excision repair (RER). Impairment of this 
pathway results in the increased genomic incorporation of 
ribonucleotides [8]. Similarly, in DTYMK deficiency, ribo-
nucleotide incorporation is explained by the lack of suffi-
cient postnatal availability of one of the building blocks of 
DNA, due to a complete block of the biosynthetic pathway 
of dTTP.
A notable difference between the human phenotype and 
the dtymk-deficient zebrafish model is the degree in which 
eye development is affected. In both individuals, some 
degree of visual impairment was noted as the individu-
als showed no visual tracking of objects and were thought 
only to be able to distinguish light and dark. However, the 
eyes were morphologically normal in both individuals. In 
the zebrafish model, there is a severe eye phenotype con-
sisting of smaller, deformed eyes lacking multiple cellular 
layers (Supplementary Fig. 2d, online resource). Similar 
eye phenotypes have been reported in knockout models of 
other enzymes of nucleotide metabolism [38]. In perplexed 
mutants, which have a pathogenic variant in cad (carbamoyl-
phosphate synthase 2, aspartate transcarbamylase and dihy-
droorotase), the enzyme active in the initial step of de novo 
dTTP synthesis (Fig. 1a), eye defects are similar to dtymk-
deficient embryos: eyes are small and lack retinal lamina-
tion (Supplementary Fig. 2d, online resource) [38]. Other 
phenotypic features of perplexed mutants include absence of 
the lower jaw cartilage. This cartilage defect is also observed 
in dtymk mutants (Fig. 3c). A second mutant affecting de 
novo synthesis is hi688, which is defective in ribonucleotide 
reductase R2 (rrm2), is early lethal and leads to a general 
degeneration phenotype [11, 38]. This phenotype is also 
reminiscent of the dtymk phenotype in which early lethality 
and general degeneration is observed.
We provide additional insight into the phenotypic presen-
tation of severely compromised dTMPK activity. We show a 
marked impairment in DNA replication in fibroblasts of an 
affected individual (Fig. 4c). In addition, we demonstrated 
significantly reduced cellular proliferation (Fig. 4d) and 
apoptosis (Fig. 4e, f) in the brain of dtymk mutant zebrafish 
and elevated levels of UV-induced γH2AX suggestive of 
elevated genomic instability in zebrafish embryos (Fig. 5c, 
d). Genome instability is most probably caused by ribonu-
cleotide incorporation in the genome (Fig. 5a, b). Ribonu-
cleotide incorporation is one of the most abundant forms of 
DNA damage in eukaryotic cells, making the DNA more 
fragile [21, 23, 36]. Therefore, a repair mechanism: RER, 
is in place to remove ribonucleotides from genomic DNA. 
A critical component of RER is RNaseH2 [19]. Mouse 
mutants for RNaseH2 accumulate large numbers of ribonu-
cleotides in their genomic DNA resulting in genome insta-
bility, arrest in cellular proliferation and a p53-dependent 
DNA-damage response [6, 28]. We show that dtymk mutant 
zebrafish exhibit elevated incorporation of ribonucleo-
tides in the genomic DNA (Fig. 5a, b). When compared to 
genomic DNA of Rnaseh2 –/– mice, the dtymk –/– genomic 
DNA shows as similar behavior on alkaline gels: a broad 
smear of lower molecular weight and reduced intensity due 
to increased degradation (Supplementary Fig. 3c, online 
Fig. 5  Ribonucleotide incorporation and DNA damage signaling. 
a Representative image of alkaline gel electrophoresis of genomic 
DNA. Genomic DNA of dtymk mutant embryos (dtymk –/–) and 
sibling (sibs) embryos at 5dpf was subjected to alkaline gel electro-
phoresis. The first two lanes contain 5 μg of genomic DNA of sibling 
(Sibs) and dtymk homozygous mutant (dtymk –/–) embryos, respec-
tively. The following two lanes contain 2.5  μg of genomic DNA of 
sibling (Sibs) and dtymk homozygous mutant (dtymk –/–) embryos, 
respectively. The first and last lane contain the marker Generuler 1 kb 
Plus DNA ladder (Thermo Fisher). Three biological replicates pro-
duced highly similar results. b Quantification of alkaline gel electro-
phoresis. Densiometric intensity values of a line drawn from the slot 
to the bottom of the gel were determined using ImageJ and plotted 
as a function of distance in the gel. The genomic DNA of homozy-
gous mutant (dtymk –/–) embryos, marked in orange, migrates at a 
lower molecular weight as the DNA of sibling embryos, marked in 
blue. Results indicate an increased sensitivity to alkaline hydroly-
sis of the genomic DNA of homozygous dtymk mutant (dtymk –/–) 
embryos. The position of the molecular weight marker is indicated 
by the grey line and its respective peaks corresponding to different 
molecular weights are indicated in the x-axis (gel position). c Repre-
sentative images of side view (upper panels) and dorsal view (lower 
panels) of embryos at 2dpf showing sites of DNA-damage, visual-
ized by γH2AX-staining (black dots). DNA damage was induced by 
UV-irradiation at 24hpf followed by a recovery time of 24 h. The left 
panels show sibling embryos (dtymk+/+, +/−) and the right panels 
show mutant (dtymk –/–) embryos. The mutant embryos clearly show 
many sites of unrepaired DNA-damage, whereas the sibling embryos 
hardly show any sites of DNA-damage. Embryos were imaged using 
identical camera and illumination settings. The scale bar represents 
200  μm. d Quantification of the phenotypic fraction of embryos 
at 2dpf that show a high amount (high) vs. a low amount (low) of 
sites of DNA damage. The phenotypic fraction is consistent with the 
expected fraction of 25% as expected from a heterozygous incross of 
heterozygous dtymk fish. The genotype of the low vs. high phenotypic 
fraction was verified by Sanger sequencing. The number of embryos 
included in the analysis is n = 13 for embryos with high amounts of 
staining (dtymk mutants) and n = 38 for sibling embryos showing low 





resource). The elevated accumulation of ribonucleotides in 
genomic DNA associated with impaired DNA replication, 
reduced cellular proliferation and elevated DNA damage 
response signaling represents a plausible explanation for 
the severe phenotypic presentation and the early embry-
onic lethality (40% death at 5dpf) observed in dtymk mutant 
zebrafish. This scenario may contribute to the progressive 
loss of cerebral cortex tissue in the individuals carrying 
DTYMK variants [1, 34].
It is remarkable that an apparently complete DTYMK 
deficiency is compatible with life. Due to a complete block 
in the metabolic pathway for dTTP synthesis, an essential 
building block of DNA cannot be generated. There is no 
known alternative biochemical pathway that could provide 
an adequate supply of dTTP to sustain DNA replication and 
repair as both known pathways (de novo and salvage path-
way) converge before the defect in DTYMK (Fig. 1a). This 
raises two outstanding questions: First, what is the com-
pensation mechanism allowing fetal brain development and 
survival until birth without the ability to generate dTTP? 
Second, why is the brain most affected? One possibility is 
that the missense alleles described in the two families in this 
study still show minimal residual activity, sufficient for very 
limited DNA synthesis and repair. On the other hand, the 
Fig. 6  Mitochondrial DNA copy number, integrity and complex 
activity. a Relative mtDNA copy number in fibroblasts of individual 
I, the parents of individual I and 5 healthy controls. mtDNA copy 
number was assessed by comparing expression levels of a mitochon-
drial DNA fragment (D-loop) versus a nuclear encoded gene (B2M). 
Relative mtDNA copy number was calculated by calculating ΔCT 
(= CT nuclear gene, B2M–CT mitochondrial gene, D-loop) and con-
verting ΔCT to relative expression levels (relative expression =  2∆CT) 
[31]. Results are pooled values from 4 experiments and plotted as 
average ± SEM. b MtDNA integrity by long-range PCR. Lane 1 and 2 
contain DNA ladders (m); 1 kb Plus ladder and (M); HindIII-digested 
λDNA fragments ladder, respectively. Lanes 3–6 contain anonymized 
diagnostic samples, lane 7 contains the sample of individual I, lane 8 
the father of individual I and lane 9 the mother of individual I. Lane 
10–12 also contain anonymized diagnostic samples. This procedure 
is a diagnostic test, performed at Clinical Genetics at Maastricht 
UMC + . No large mtDNA deletions could be observed. c Mitochon-
drial respiratory complex activity. Enzymatic activity of mitochon-
drial respiratory complexes I–V were measured using a spectropho-
tometer in lysates of cultured fibroblasts [33]. Relative values are 
calculated using the value of Citrate Synthase activity as the reference 
value. Bars are averages of 2 measurements. This assay is a diagnos-




zebrafish model is a frameshift allele giving rise to a grossly 
truncated protein with almost undetectable enzyme activity. 
The phenotypic similarity of this loss-of-function allele in 
the zebrafish to that of the affected individuals coupled to 
the fact that both models show almost undetectable dTMPK 
enzyme activity strongly suggest that the human variants are 
loss-of-function variants.
The fact that both in fibroblast as in zebrafish models, 
dTTP nucleotide levels resemble those of normal controls 
(Supplementary Fig. 3a, b, online resource) together with 
the fact that both affected individuals and the homozygous 
zebrafish survive beyond birth could suggest the intriguing 
possibility of a compensatory pathway for dTTP genera-
tion. A prima facie candidate enzyme would be TMPK2 
(or UMP-CMP kinase 2, CMPK2) [7, 39]. However, as 
this enzyme has no apparent capability to use dTMP as a 
substrate [5, 7, 39] it would appear unlikely that CMPK2 
can fulfill this function. Thus, a compensatory pathway for 
dTTP generation remains to be proven.
It is known that imbalanced dNTP pools cause repli-
cation stress that can in turn trigger neuronal apoptosis 
[25]. Widespread apoptosis is what was observed in the 
brains of our affected individuals, and in the zebrafish. 
Why neurons are particularly vulnerable to this imbal-
ance is not clear at this time. A restricted expression pat-
tern of DTYMK is unlikely to be the answer as DTYMK is 
expressed in all human tissues. Cerebral cortex, hippocam-
pus and caudate nucleus show medium expression, while 
cerebellum has high protein expression (https:// www. prote 
inatl as. org/ ENSG0 00001 68393- DTYMK/ tissue). Inter-
estingly, expression in brain mouse embryo (E15) (http:// 
www. infor matics. jax. org/ marker/ MGI: 108396) shows 
highest Dtymk expression levels in the forebrain, moderate 
levels in the midbrain (tectum) and low expression in the 
hindbrain. This might provide a clue to why the forebrain-
derived structures (cerebral cortex and basal ganglia) are 
most affected in the described individuals. Alternatively, 
a restricted expression pattern of a putative compensatory 
enzyme could explain the vulnerability of the brain in this 
disease.
In conclusion, we show that novel germline variants 
in DTYMK cause profound postnatal neurodegeneration 
and marked developmental arrest. Our studies directly link 
thymidine biosynthesis to genome integrity and postnatal 
neuronal viability.
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